Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis

B Kisacik, A Tufan, U Kalyoncu, O Karadag, A Akdogan… - Joint bone spine, 2008 - Elsevier
AIMS: The aim of this retrospective study was to investigate the correlation between MPV
and the clinical disease activity indices of rheumatoid arthritis and ankylosing spondylitis. …

A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of …

…, M de Wit, U Kiltz, J Braun, U Kalyoncu… - Annals of the …, 2014 - ard.bmj.com
Introduction The objective was to develop a questionnaire that can be used to calculate a
score reflecting the impact of psoriatic arthritis (PsA) from the patients’ perspective: the PsA …

[HTML][HTML] Behçet disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapses

…, Y Karaaslan, M Sayarloglu, Y Pehlivan, U Kalyoncu… - Medicine, 2015 - journals.lww.com
Vascular involvement is one of the major causes of mortality and morbidity in Behçet disease
(BD). There are no controlled studies for the management of vascular BD (VBD), and …

Familial Mediterranean fever and central nervous system involvement: a case series

U Kalyoncu, A Eker, KK Oguz, A Kurne, I Kalan… - Medicine, 2010 - journals.lww.com
We conducted this study to determine familial Mediterranean fever (FMF)-associated central
nervous system involvement including demyelinating lesions, stroke, and posterior …

The Psoriatic Arthritis Registry of Turkey: results of a multicentre registry on 1081 patients

U Kalyoncu, Ö Bayindir, M Ferhat Öksüz… - …, 2016 - academic.oup.com
Objective. The aim was to assess the characteristics of PsA, find out how well the disease is
controlled in real life, demonstrate the treatments and identify the unmet needs. Methods. …

International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials

…, S Hewlett, P Hoejgaard, U Kalyoncu… - Annals of the …, 2017 - ard.bmj.com
Objective To identify a core set of domains (outcomes) to be measured in psoriatic arthritis (PsA)
clinical trials that represent both patients' and physicians' priorities. Methods We …

Effect of anti-TNF treatment on sleep problems in ankylosing spondylitis

Ö Karadağ, D Nakas, U Kalyoncu, A Akdoğan… - Rheumatology …, 2012 - Springer
Sleep disturbances and problems are increased in ankylosing spondylitis (AS). But much is
not known in a quantitative way about sleep problems and effect of treatments on AS. This …

Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study

…, T Temel, F Sahin, S Akar, K Aksu, U Kalyoncu… - …, 2014 - academic.oup.com
Objective. The primary aim of this study was to investigate the prevalence of amyloidosis
and its related factors in a large number of FMF patients. Methods. Fifteen centres from the …

Are familial Mediterranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in …

…, M Calguneri, B Yavuz, EB Arslan, U Kalyoncu… - Journal of the American …, 2006 - jacc.org
It provides a stimulus for exploring the benefits of stem cell therapy in nonischemic dilated
cardiomyopathy. A double-blind study is being planned to further explore the benefit seen in …

Monitoring Achilles enthesitis in ankylosing spondylitis during TNF-α antagonist therapy: an ultrasound study

…, P Atagunduz, A Akdogan, U Kalyoncu… - …, 2010 - academic.oup.com
Objective. Enthesitis is considered as the primary anatomical lesion in ankylosing spondylitis
(AS). Therapeutic effects of TNF-α antagonist treatments for enthesitis on imaging changes …